About Vinther LifeScience
Vinther LifeScience Advisory offers consultancy within value development and value assessment on a project or freelance basis.
Grow with a data and evidence driven commercial strategy
Vinther LifeScience Advisory offers consultancy within value development and value assessment on a project or freelance basis.
The company is founded and owned by me, Rasmus Vinther Russell. I have more than a decade of experience within LifeScience across MedTech and Pharma. Here, I have hands-on experience and developed expertise within translational medicine, health economics, outcome research and market access.
With a background in translational medicine, I started my LiveScience career within pre-clinical development and clinical trial design and have later in my career headed up global health economics and market access.
I regard value development and assessment as an ever-evolving iterative process. Value development and assessment must consider how the solution brings value to patients, healthcare workers and healthcare providers within a dynamic market with changing decision criteria, new comparators, changing financial environments and an evolving patient population. Accordingly, evidence generation, value communication, access projects and pricing need to be continuously adjusted to ensure that solutions meet their full market potential.
Given my global experience, I offer a global strategic outlook and look forward to help you with your evidence generation, value communication, access projects and pricing.
I offer an honest service based on my experience from within the industry, and I tailor each project to your needs and demands.
Be confident with a marketing and market access strategy backed by powerfull evidence
Value Proposition
Establishing an accurate value proposition reflecting the value-add for specific market segments or sub-populations are crucial for the commercial success of your solution. A good value prop can be your north star throughout development, pricing, go-to-market, access, evidence and sales strategy.
Evidence generation
Evidence-based decision-making is key within evidence-based medicine. The evidence requirements, change between personas, institutions, payers or purchasing organizations, highlighting the necessity to execute evidence strategies tailored to ensure market access and market acceptance. Evidence generation is an ongoing process throughout the solutions lifecycle, from bench to bedside and onwards.
Market Access
Leveraging market access opportunities is increasingly becoming a competitive edge in a fast-changing market. Value-based healthcare require manufactures to prove a relevant value-gain to decision makers within multiple different institutions, payers and purchasing organizations.
Value Communication
Articulation and contextualization of the evidence-based value proposition is crucial to ensure that relevant stakeholders understand how your solution helps them meet their goals and aspirations. It is becoming more and more usual that decision makers responsible for procurement, reimbursement and appraisals review manufactures communication across multiple channels and not merely the forwarded materials and pitches. Solid value communication strategies ensure consistent messaging to stakeholders across channels. This includes investor relation communication, pitches targeting policy makers, scientific peer-review articles or abstracts to communicate to scientific stakeholders like physicians or pharmacists, full value dossiers for HTA or reimbursement negotiations, dynamic sales tools to negotiate at a provider or hospital level, and marketing communication to build brand awareness via e.g. SoMe.
